For this purpose, we selected PRX-119, a PEGylated recombinant human DNase I that exhibits extended half-life in the circulation and has previously shown efficacy in sepsis mouse model of NET-related disease (Sharma et al. 2025). The gene discussed is PRX; the disease is Sepsis.